U.S. NeuroSurgical Holdings, Inc. (USNU) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21
	10-Q	10-Q	10-Q	10-Q	10-Q	10-K/A	10-Q	10-Q
Revenues			0.0	0.0	0.0	1.1	2.2	2.9
Revenue growth			-100.0%	-100.0%	-100.0%	-66.6%	-19.0%	5.2%
Cost of goods sold			0.0	0.0	0.0	0.0	0.0	0.0
Gross profit			0.0	0.0	0.0	1.1	2.2	2.9
Gross margin						100.0%	100.0%	100.0%
Selling, general and administrative [+]			1.1	1.2	1.1	1.1	1.1	1.1
Sales and marketing			0.9	0.9	0.9		0.8	0.8
General and administrative						0.2
Equity in earnings			-1.4	-1.3	-0.5	-0.5	-0.9	-0.8
EBIT [+]			-2.5	-2.5	-1.6	-0.6	0.1	0.7
EBIT growth			-2224.4%	-460.7%	-241.6%	-169.4%	-58.0%	226.4%
EBIT margin						-52.7%	5.3%	23.9%
Interest expense								0.0
Interest expense								0.0
Other income (expense), net [+]						0.0	0.0
Other						-0.3	-0.3	-0.3
Pre-tax income			-2.5	-2.5	-1.6	-0.6	0.1	0.7
Income taxes			0.2	0.2	0.5	0.7	0.7	0.7
Minority interest			-0.4	-0.4	-0.2	-0.1
Net income			-2.3	-2.4	-1.9	-1.2	-0.5	0.0
Net margin						-111.2%	-23.7%	-0.4%

Basic EPS [+]			($0.30)	($0.30)	($0.24)	($0.15)	($0.07)	$0.00
Growth			343.6%	19675.0%	-391.2%	-321.4%	-285.9%	-105.1%
Diluted EPS [+]			($0.30)	($0.30)	($0.24)	($0.15)	($0.07)	$0.00
Growth			343.6%	19675.0%	-391.2%	-321.4%	-285.9%	-105.1%

Shares outstanding (basic)			7.8	7.8	7.8	7.8	7.8	7.8
Growth			0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Shares outstanding (diluted)			7.8	7.8	7.8	7.8	7.8	7.8
Growth			0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.